We are live on ! Find out more
PP

Pegasus Partners Portfolio holdings

AUM $1.07B
1-Year Est. Return 32.32%
This Fund
S&P 500
This Quarter Est. Return
+8.82%
1 Year Est. Return
+32.32%
3 Year Est. Return
+32.61%
5 Year Est. Return
+96.28%
10 Year Est. Return
AUM
$944M
AUM Growth
+$87.3M
Cap. Flow
+$14.1M
Cap. Flow %
1.5%
Top 10 Hldgs %
66.82%
Holding
159
New
16
Increased
34
Reduced
57
Closed
9

Sector Composition

Rank Sector Weight
1 Technology 4.96%
2 Financials 2.42%
3 Healthcare 1.97%
4 Consumer Discretionary 1.55%
5 Communication Services 1.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADBE icon
151
Adobe
ADBE
$89.5B
-353
Closed -$211K
ALTO icon
152
Alto Ingredients
ALTO
$360M
-50,000
Closed -$133K
CWB icon
153
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.64B
-11,980
Closed -$864K
DIA icon
154
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$45.8B
-590
Closed -$222K
EXPD icon
155
Expeditors International
EXPD
$22.9B
-1,670
Closed -$212K
OCUL icon
156
Ocular Therapeutix
OCUL
$1.86B
-25,000
Closed -$112K
PFE icon
157
Pfizer
PFE
$140B
-46,700
Closed -$1.34M
ST icon
158
Sensata Technologies
ST
$6.65B
-8,500
Closed -$319K
VBR icon
159
Vanguard Small-Cap Value ETF
VBR
$37.1B
-4,768
Closed -$858K

Similar funds

Pegasus Partners's Q1 2024 Portfolio in Review

As of Q1 2024, Pegasus Partners held 159 positions worth $944M, up 10% from $856M the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Pegasus Partners's Q1 2024 filing shows 16 new, 34 increased, 57 reduced and 9 closed positions. Its largest new stake was Zoetis: 6,721 shares worth $1.14M. The largest sale was iShares Russell Mid-Cap ETF, an estimated $1.78M.

By sector, the portfolio is most concentrated in Technology at 5% of assets, down from 5.6% a quarter earlier, followed by Financials and Healthcare.

  • Pegasus Partners's largest Q1 2024 buy was Zoetis: 6,721 shares worth $1.14M.
  • Pegasus Partners added most to iShares Russell Top 200 Growth ETF in Q1 2024, an estimated $13.6M increase.
  • Pegasus Partners's biggest Q1 2024 reduction was iShares Russell Mid-Cap ETF, cutting an estimated $1.78M.
  • Pegasus Partners fully exited Pfizer in Q1 2024, selling an estimated $1.34M.
  • Pegasus Partners's ten largest holdings make up 67% of its $944M portfolio in Q1 2024.
  • Pegasus Partners opened 16 new positions and closed 9 in Q1 2024.
  • Pegasus Partners's portfolio value rose 10% quarter-over-quarter to $944M.

Based on Pegasus Partners's 13F filing for Q1 2024, filed 24 Apr 2024.